Skip to content
Live funding
Sesame Summit 2027
Sesamers
4BIO Capital

4BIO Capital

● Actively deploying London, UK · Founded 2014

Investment thesis

Early-stage advanced therapies: cell therapy, gene therapy, RNA-based therapy, targeted therapies and microbiome-based treatments

Sesamers tracks 3 portfolio companies across 3 rounds, 3 of them as lead investor. Its most recent tracked deal: Oyster Therapeutics, Nov 2026.

Portfolio

Past investments

Company Round Role Date Round size
Oyster Therapeutics London, United Kingdom Read the announcement → Series A Lead Nov 2026 €54.1M
Undecimal Bio Cambridge, United Kingdom Read the announcement → Seed Lead Oct 2026 €16M
Aptadir Therapeutics Milan, Italy Read the announcement → Seed Lead Sep 2026 €40M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.